SUPPORT FROM MEDICAL ORGANIZATIONS Various professional organizations recognize the therapeutic benefits of marijuana and support its rescheduling to facilitate more research and reduce regulatory barriers. This support underscores the medical community's confidence in marijuana's safety and efficacy. REGULATORY AND ECONOMIC BENEFITS Rescheduling marijuana to Schedule III will enable more research and development into its medical uses, potentially leading to new treatments and medications. It will also align with international treaty obligations, ensuring compliance while allowing for domestic regulatory flexibility.
CONCLUSION
Rescheduling marijuana to Schedule III is a scientifically and medically justified step that acknowledges its therapeutic benefits while ensuring proper regulatory oversight. This change will benefit patients, support economic growth, particularly in minority communities, and align with both domestic and international regulatory standards. I urge the DEA to proceed with rescheduling marijuana to Schedule III to reflect its lower abuse potential and recognized medical use
Thank you for considering my comments
Sincerely,
[Your Name]
Members and advocates can use this letter as a template to submit their comments to the DEA Rules Making public comment site at regulations.gov.
PAGE 12
Made with FlippingBook - professional solution for displaying marketing and sales documents online